The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 24, 2012
Filed:
May. 23, 2006
Junghyun Nam, Gyeonggi-do, KR;
Hyojung MO, Ansan-si, KR;
Wonjin Lee, Seoul, KR;
Juhyun Han, Seongnam-si, KR;
Heuikeun Kang, Hwaseong-si, KR;
Junghak Cha, Gunpo-si, KR;
Jindong Chang, Seoul, KR;
Eunjeong Lim, Suwon-si, KR;
JungHyun Nam, Gyeonggi-do, KR;
HyoJung Mo, Ansan-si, KR;
WonJin Lee, Seoul, KR;
JuHyun Han, Seongnam-si, KR;
HeuiKeun Kang, Hwaseong-si, KR;
JungHak Cha, Gunpo-si, KR;
JinDong Chang, Seoul, KR;
EunJeong Lim, Suwon-si, KR;
Humasis Co., Ltd., , KR;
Abstract
The present invention relates to a diagnostic device for measuring the ratio of similar structural proteins among the proteins secreted in a liquid test sample taken from diagnosis subject. In further detail, the test device according to the present invention comprises detection marker-antibody conjugate recognizing the same site on two or more similar structural proteins and a detection zone in which antibody specifically recognizes each of said proteins via formation of sandwich type complex, wherein said antibodies form a set, and the present Invention relates to a diagnostic device for early diagnosis of polycystic ovary syndrome, abnormal pregnancy, prostatic carcinoma etc. based on determination of the ratio of follicle stimulating hormone and luteinizing hormone in case of polycystic ovary syndrome, the ratio between hCG isomers in case of abnormal pregnancy, and the ratio of prostate-specific antigens (PSA) in case of prostatic carcinoma.